help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Christofori, G.
Right arrow Articles by Hanahan, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Christofori, G.
Right arrow Articles by Hanahan, D.

Molecular Endocrinology, Vol 9, 1760-1770, Copyright © 1995 by Endocrine Society

ARTICLES

Vascular endothelial growth factor and its receptors, flt-1 and flk-1, are expressed in normal pancreatic islets and throughout islet cell tumorigenesis

G Christofori, P Naik and D Hanahan
Department of Biochemistry and Biophysics, University of California, San Francisco 94143-0534, USA.

Endocrine organs, such as the pancreatic islets of Langerhans, contain permeable, fenestrated endothelium that allows direct access of endocrine cells to the blood stream. Factors that control differentiation and maintenance of this highly specialized endothelium remain unknown. Vascular endothelial growth factor (VEGF) is a multifunctional growth factor that may be responsible for the homeostasis of endocrine endothelium; it is a selective mitogen for endothelial cells and is able to permeabilize endothelium. We have analyzed the expression of VEGF mRNA and protein in pancreatic islet cells of normal mice and during the different stages of tumor progression in a transgenic mouse model of beta-cell carcinogenesis. The 120-amino acid and the 164-amino acid isoforms of VEGF are expressed in normal islets of Langerhans and are moderately up- regulated during the stages of tumor development. Two high-affinity receptors for VEGF, flt-1 and flk-1, are expressed by endothelial cells both in normal islets and in the stages of tumorigenesis; these receptors are not up-regulated during this process. Our data raise the possibility that VEGF is involved in the maintenance of permeable endothelium in islets of Langerhans, an observation that may have implications for islet cell physiology and diabetes. While VEGF may also play an important role in the growth of new blood vessels during islet cell tumorigenesis, it cannot be the only factor required for the activation of tumor angiogenesis.


This article has been cited by other articles:


Home page
 DiabetesHome page
R. Miller, V. Cirulli, G. R. Diaferia, S. Ninniri, G. Hardiman, B. E. Torbett, R. Benezra, and L. Crisa
Switching-On Survival and Repair Response Programs in Islet Transplants by Bone Marrow-Derived Vasculogenic Cells
Diabetes, September 1, 2008; 57(9): 2402 - 2412.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
J. M. Oliver-Krasinski and D. A. Stoffers
On the origin of the {beta} cell
Genes & Dev., August 1, 2008; 22(15): 1998 - 2021.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
M. H. Kulke, H.-J. Lenz, N. J. Meropol, J. Posey, D. P. Ryan, J. Picus, E. Bergsland, K. Stuart, L. Tye, X. Huang, et al.
Activity of Sunitinib in Patients With Advanced Neuroendocrine Tumors
J. Clin. Oncol., July 10, 2008; 26(20): 3403 - 3410.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
M. L. Springer, A. Banfi, J. Ye, G. von Degenfeld, P. E. Kraft, S. A. Saini, N. K. Kapasi, and H. M. Blau
Localization of vascular response to VEGF is not dependent on heparin binding
FASEB J, July 1, 2007; 21(9): 2074 - 2085.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
M. H Kulke
Gastrointestinal neuroendocrine tumors: a role for targeted therapies?
Endocr. Relat. Cancer, June 1, 2007; 14(2): 207 - 219.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
A. E. Roberts, L. K. Arbogast, C. I. Friedman, D. E. Cohn, P. T. Kaumaya, and D. R. Danforth
Neutralization of Endogenous Vascular Endothelial Growth Factor Depletes Primordial Follicles in the Mouse Ovary
Biol Reprod, February 1, 2007; 76(2): 218 - 223.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
X. Li, L. Zhang, S. Meshinchi, C. Dias-Leme, D. Raffin, J. D. Johnson, M. K. Treutelaar, and C. F. Burant
Islet Microvasculature in Islet Hyperplasia and Failure in a Model of Type 2 Diabetes
Diabetes, November 1, 2006; 55(11): 2965 - 2973.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
M. Brissova, A. Shostak, M. Shiota, P. O. Wiebe, G. Poffenberger, J. Kantz, Z. Chen, C. Carr, W. G. Jerome, J. Chen, et al.
Pancreatic Islet Production of Vascular Endothelial Growth Factor-A Is Essential for Islet Vascularization, Revascularization, and Function
Diabetes, November 1, 2006; 55(11): 2974 - 2985.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
B. Schaffhauser, T. Veikkola, K. Strittmatter, H. Antoniadis, K. Alitalo, and G. Christofori
Moderate antiangiogenic activity by local, transgenic expression of endostatin in Rip1Tag2 transgenic mice
J. Leukoc. Biol., October 1, 2006; 80(4): 669 - 676.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M. Johansson, G. Mattsson, A. Andersson, L. Jansson, and P.-O. Carlsson
Islet Endothelial Cells and Pancreatic {beta}-Cell Proliferation: Studies in Vitro and during Pregnancy in Adult Rats
Endocrinology, May 1, 2006; 147(5): 2315 - 2324.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
V. J. Yao, M. G. Ozawa, A. S. Varner, I. M. Kasman, Y. H. Chanthery, R. Pasqualini, W. Arap, and D. M. McDonald
Antiangiogenic therapy decreases integrin expression in normalized tumor blood vessels.
Cancer Res., March 1, 2006; 66(5): 2639 - 2649.
[Abstract] [Full Text] [PDF]

Home page
 J. Histochem. Cytochem.Home page
E. Bertelli and M. Bendayan
Association between Endocrine Pancreas and Ductal System. More than an Epiphenomenon of Endocrine Differentiation and Development?
J. Histochem. Cytochem., September 1, 2005; 53(9): 1071 - 1086.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
H. E. Turner, A. L. Harris, S. Melmed, and J. A. H. Wass
Angiogenesis in Endocrine Tumors
Endocr. Rev., October 1, 2003; 24(5): 600 - 632.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
S. Boujendar, E. Arany, D. Hill, C. Remacle, and B. Reusens
Taurine Supplementation of a Low Protein Diet Fed to Rat Dams Normalizes the Vascularization of the Fetal Endocrine Pancreas
J. Nutr., September 1, 2003; 133(9): 2820 - 2825.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
T. UDAGAWA, A. FERNANDEZ, E.-G. ACHILLES, J. FOLKMAN, and R. J. D'AMATO
Persistence of microscopic human cancers in mice: alterations in the angiogenic balance accompanies loss of tumor dormancy
FASEB J, September 1, 2002; 16(11): 1361 - 1370.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
T. M. J. Niederman, Z. Ghogawala, B. S. Carter, H. S. Tompkins, M. M. Russell, and R. C. Mulligan
Antitumor activity of cytotoxic T lymphocytes engineered to target vascular endothelial growth factor receptors
PNAS, May 14, 2002; 99(10): 7009 - 7014.
[Abstract] [Full Text] [PDF]

Home page
 J. Histochem. Cytochem.Home page
S. Vidal, R. V. Lloyd, L. Moya, B. W. Scheithauer, and K. Kovacs
Expression and Distribution of Vascular Endothelial Growth Factor Receptor Flk-1 in the Rat Pituitary
J. Histochem. Cytochem., April 1, 2002; 50(4): 533 - 540.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
G. Gannon, S. J. Mandriota, L. Cui, D. Baetens, M. S. Pepper, and G. Christofori
Overexpression of Vascular Endothelial Growth Factor-A165 Enhances Tumor Angiogenesis but not Metastasis during {beta}-Cell Carcinogenesis
Cancer Res., January 1, 2002; 62(2): 603 - 608.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
P. Guo, L. Xu, S. Pan, R. A. Brekken, S.-T. Yang, G. B. Whitaker, M. Nagane, P. E. Thorpe, J. S. Rosenbaum, H.-J. Su Huang, et al.
Vascular Endothelial Growth Factor Isoforms Display Distinct Activities in Promoting Tumor Angiogenesis at Different Anatomic Sites
Cancer Res., December 1, 2001; 61(23): 8569 - 8577.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. Fang, L. Yan, Y. Shing, and M. A. Moses
HIF-1{alpha}-mediated Up-Regulation of Vascular Endothelial Growth Factor, Independent of Basic Fibroblast Growth Factor, Is Important in the Switch to the Angiogenic Phenotype during Early Tumorigenesis
Cancer Res., August 1, 2001; 61(15): 5731 - 5735.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. Compagni, P. Wilgenbus, M.-A. Impagnatiello, M. Cotten, and G. Christofori
Fibroblast Growth Factors Are Required for Efficient Tumor Angiogenesis
Cancer Res., December 1, 2000; 60(24): 7163 - 7169.
[Abstract] [Full Text]

Home page
 FASEB J.Home page
T. A. PARTANEN, J. AROLA, A. SAARISTO, L. JUSSILA, A. ORA, M. MIETTINEN, S. A. STACKER, M. G. ACHEN, and K. ALITALO
VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor, VEGFR-3, in fenestrated blood vessels in human tissues
FASEB J, October 1, 2000; 14(13): 2087 - 2096.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
H. E. Ryan, M. Poloni, W. McNulty, D. Elson, M. Gassmann, J. M. Arbeit, and R. S. Johnson
Hypoxia-inducible Factor-1{{alpha}} Is a Positive Factor in Solid Tumor Growth
Cancer Res., August 1, 2000; 60(15): 4010 - 4015.
[Abstract] [Full Text]

Home page
 Clin. Cancer Res.Home page
J. Mattern, R. Koomagi, and M. Volm
Biological Characterization of Subgroups of Squamous Cell Lung Carcinomas
Clin. Cancer Res., June 1, 1999; 5(6): 1459 - 1463.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Ophthalmol.Home page
G. Smith, D. McLeod, D. Foreman, and M. Boulton
Immunolocalisation of the VEGF receptors FLT-1, KDR, and FLT-4 in diabetic retinopathy
Br. J. Ophthalmol., April 1, 1999; 83(4): 486 - 494.
[Abstract] [Full Text]

Home page
 ScienceHome page
E. Lammert, O. Cleaver, and D. Melton
Induction of Pancreatic Differentiation by Signals from Blood Vessels
Science, October 19, 2001; 294(5542): 564 - 567.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1995 by The Endocrine Society